Nominations Currently Closed

Thank you for the outstanding response in 2017!

Nomination Information

It is a simple process to nominate an individual who you feel has contributed significantly in Crohn’s and colitis patient care, medical research, public service, and professional / public education. Your next opportunity to nominate will be in 2018. Please click below to sign up for the latest updates.


Candidates can be nominated by colleagues, peers, advocates, educators — anyone who can attest to the candidate’s qualifications. Self-nominations cannot be accepted.


The Sherman Prize is open to a broad range of contributors in the fight to overcome Crohn’s disease and ulcerative colitis, recognizing those with significant achievements in one or more of the following areas:

Patient Care

Health care professionals who provide extraordinary, responsive clinical care, or make strides to improve the physical, emotional and / or psychosocial aspects of treatment.

Medical Research

Medical and research professionals who perform groundbreaking scientific research.

Public Service & Professional / Public Education

Health care providers, educators, and advocates who go above and beyond in support of awareness, education and advocacy.

Eligible individuals must live and work in the U.S. and demonstrate an outstanding commitment to IBD work, having accomplished their greatest achievements within the past decade, preferably within the past two years.

Nominees who aren’t selected can be nominated again in coming years, should the individual still meet the eligibility requirements.

Explore More Detail on Eligibility

Patient Care

  • Identifying risk factors for Crohn’s and colitis and improving diagnosis.
  • Improving patients’ quality of care, and their social and emotional well-being.
  • Supporting emerging clinicians to make a significant impact on the field.
  • Providing patients with the opportunity to make informed decisions about their care and treatment, as well as strong and culturally appropriate communication tailored to the patient’s needs.
  • Providing families and caregivers with information and support.
  • Providing outstanding care demonstrating mastery of the clinical management of compassionate and effective treatment of IBD patients.

Medical Research

  • Studying risk factors for Crohn’s and colitis in an effort to improve diagnosis.
  • Determining the environmental and/or genetic factors that enhance the risk of Crohn’s and colitis.
  • Deepening our understanding of the multiple disease processes under the umbrella of Crohn’s and colitis.
  • Developing tools that will predict the aggressiveness of the disease, whether complications will develop, and how individual patients will respond to particular therapies.
  • Studying new medications and treatments that induce remission and prevent relapse.
  • Discovering ways to prevent complications.
  • Encouraging multidisciplinary research focused on new technologies and systems to treat and cure Crohn’s and colitis.
  • Predicting and preventing the onset of diseases in high-risk individuals.

Public Service & Professional / Public Education

  • Enhancing support for people with Crohn’s and colitis through support groups or peer-to-peer assistance.
  • Leading advocacy efforts to enhance public policies on behalf of those with Crohn’s and colitis.
  • Training and inspiring the next generation of gastroenterology specialists through superb teaching.
  • Leading communication and education efforts to:
    • Inform the public of the risk factors for the diseases
    • Raise awareness on the environmental and genetic factors that enhance the risk or progression of the diseases
    • Publicize new medications and treatments that induce remission and prevent relapse of the diseases.
    • Effectively educate patients and professionals about IBD.
    • Mentor and support trainees and junior faculty to develop meaningful careers in IBD.
Download PDF